Alex Anthopoulos Locks In Core Stars as Atlanta Rebuilds Pitching

Stepping to a microphone at Truist Park in Atlanta this week, general manager Alex Anthopoulos wasted zero syllables extinguishing winter trade rumors surrounding franchise right fielder Ronald Acuna Jr., declaring flatly that Atlanta needs its superstar and had no idea where the speculation originated. Days earlier, the front office backed up those words by exercising Acuna’s $17 million club option alongside second baseman Ozzie Albies’ $7 million option for 2027.

Decisive clarity at the top of the roster was overdue after a bittersweet finale at Truist Park, where a 4-1 loss to the Los Angeles Dodgers extinguished Walt Weiss’ 94-68 NL East champions in October. Over 162 regular-season games, Atlanta paired MLB’s eighth-ranked scoring attack (4.58 runs per game) with fifth-ranked run prevention (3.86 opponent runs per game), only to watch an injury-battered lineup hit .183 across seven postseason contests—setting an urgent winter blueprint ahead of February 2027.

Ninety-Four Regular-Season Wins Collide With an October Freeze

Across six grueling months from April through September, Walt Weiss steered Atlanta through relentless rotation attrition to capture the NL East at 94-68. The Braves outscored opponents by nearly three-quarters of a run per night, backing 742 regular-season runs of support (eighth in MLB) with 91 game-winning RBIs (tied for fourth) while grounding into just 89 double plays (tied for third fewest in the majors). On the mound, Atlanta logged 1,438 full regular-season frames (fourth in MLB), paced the majors with a 2.6 strikeout-to-walk ratio, and stranded 136 of 172 inherited baserunners—allowing a league-low 36 to score.

October baseball, however, exposed how thin Atlanta’s healthy offensive margin had become against elite postseason pitching. Across seven playoff games (going 3-4 over 63.0 innings), Chris Sale, closer Robert Suarez, and setup lefty Dylan Lee held opposing lineups to a 3.14 postseason ERA, a 1.05 WHIP, and a .215 opponent batting average with 60 strikeouts against 15 walks. Yet Atlanta’s bats went ice-cold under the lights, slashing .183/.294/.315 (.609 OPS) with just 22 runs, 40 hits, six homers, and 63 strikeouts in 219 postseason at-bats before bowing out 4-1 against Los Angeles.

Chris Sale’s Command, Matt Olson’s Glove, and Shortstop Questions

Everything that sustained Atlanta’s 94-win division march began with veteran poise on the infield dirt and surgical strike-throwing. First baseman Matt Olson captured his fourth career Gold Glove Award in early November while anchoring the middle of the order alongside third baseman Austin Riley, Albies, catcher Sean Murphy, and young catcher-designated hitter Drake Baldwin. Defensively across those seven October tests, Atlanta committed only four errors for a .984 postseason fielding mark, mirroring the crisp ball-security habits that defined Weiss’ club throughout the 162-game grind.

Beneath the surface, two lineup vulnerabilities hampered run creation whenever opponents pitched around Olson and Riley. First, injuries left outfielders Ronald Acuna Jr., center fielder Michael Harris II, left fielder Mike Yastrzemski, and reserve Brewer Hicklen ending the campaign on injured reserve while Jurickson Profar missed the entire season serving his second consecutive performance-enhancing drug suspension handed down in March. Second, relying on utility infielders Brett Wisely and Jim Jarvis at shortstop left a noticeable offensive void at a premium position, forcing Atlanta to grind out 3.90 pitches per plate appearance in October without generating consistent extra-base damage.

Acuna and Albies Stay Put While Elbow Rehabs Reshape the Rotation

Picking up $24 million in combined 2027 club options on Acuna ($17 million) and Albies ($7 million)—followed immediately by Anthopoulos squashing any Acuna trade chatter—locks Atlanta’s championship core firmly in place alongside Olson, Riley, Murphy, Harris, and Sale. Getting Acuna and Harris healthy off the injured-reserve list, coupled with Profar’s suspension expiring in February 2027, gives Weiss an immediate internal talent infusion before signing a single external free agent.

Where Atlanta faces sobering medical uncertainty is across a starting pitching group battered by elbow procedures. Flame-throwing right-hander Spencer Strider was limited to just eight outings in 2026 before mid-June right elbow inflammation ended his year; while physically encouraging heading toward February 2027, his workload requires careful management after a 4.45 ERA in 2025 following internal-brace surgery. Right-hander Spencer Schwellenbach—who dazzled with a 3.09 ERA and 0.97 WHIP in 2025—missed all of 2026 due to February bone-spur removal and an August elbow fracture repair, pointing toward a cautious April 2027 or delayed ramp-up. Meanwhile, Hurston Waldrep will miss all of 2027 after right Tommy John surgery, and waiver-claim lefty Mitchell Parker (late-July internal-brace elbow surgery) may not pitch again until late 2027 or 2028.

Targeting an Impact Shortstop and Durable Innings Behind Chris Sale

Anthopoulos enters the November free-agent and trade markets with two unmistakable priorities: upgrading everyday shortstop production and insulating a rotation that cannot gamble 162 games solely on elbow-rehab timelines. While Grant Holmes, Bryce Elder, and Owen Murphy provide capable back-end starting depth—supplemented by relievers Reynaldo Lopez, Dylan Dodd, Joey Wentz (recovering from a knee issue toward February 2027), Ray Kerr, Michael Grove, James Karinchak, Blake Burkhalter, Rolddy Munoz, Tyler Uberstine, and Didier Fuentes—Atlanta needs a battle-tested No. 2 or No. 3 starter to bridge the first half of 2027 while Strider and Schwellenbach build stamina.

Positionally, acquiring a high-contact, plus-defensive shortstop via trade or free agency would lengthen Weiss’ batting order from top to bottom and prevent October opponents from pitching around Atlanta’s middle-of-the-order sluggers. Adding a reliable corner outfield bat to hedge against Yastrzemski’s injured-reserve recovery and Profar’s rust after missing 2026 is equally prudent. Even during the regular season, 20 blown saves reminded the front office that pairing Suarez and Lee with one more high-leverage right-handed setup arm would fortify ninth-inning leads.

Defending the NL East Crown on the Road to Spring 2027

Even after a stinging four-game postseason exit against Los Angeles, Atlanta’s 2027 contention window remains wide open at the top of the National League East. Winning 94 games while allowing 3.86 runs per contest without a full season of Strider or a single pitch from Schwellenbach speaks volumes about organizational depth and Weiss’ calm dugout command. Within the division, third-place Miami improved to 80-82 and New York looms aggressively on the winter ace market, leaving zero room for complacency in Atlanta.

When the Braves travel to Ed Smith Stadium in Sarasota to face the Baltimore Orioles in Grapefruit League play this coming spring of 2027, the narrative will center on health and lineup balance. With Acuna, Albies, Olson, Riley, and Sale anchoring the clubhouse—and provided Anthopoulos reinforces shortstop and rotation durability before February 2027—Atlanta possesses both the run-prevention pedigree and superstar ceiling to chase 95-plus wins and rewrite its October script in 2027.